# Arakis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arakis

- Industry: Pharmaceuticals
- Headquarters: Essex, UK
- Total disclosed funding: $75M
- Latest round: Series C (Aug 31, 2004)
- Investors on record: 11

## About

Arakis is a UK-based company that operates as a provider of pharmaceutical products.

## Funding rounds

- Series C, Aug 31, 2004, $52M — 3i, Scottish Equity Partners, Excalibur Fund Managers, Scottish Widows Investment Partnership, Alice Ventures, Phase4 Partners, Novo Holdings, Finsbury Life Sciences Investment Trust
- Series B, Apr 26, 2002, $23M — 3i, MB Venture Partners, Nomura Asset Management, Merlin Biosciences Fund Ltd

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series B, Series C
- MB Venture Partners (https://capitalatlas.ai/funds/mb-venture-partners) — Series B
- Nomura Asset Management (https://capitalatlas.ai/funds/nomura-asset-management) — Series B
- Merlin Biosciences Fund Ltd — Series B
- Scottish Equity Partners (https://capitalatlas.ai/funds/scottish-equity-partners) — Series C
- Excalibur Fund Managers (https://capitalatlas.ai/funds/excalibur-fund-managers) — Series C
- Scottish Widows Investment Partnership (https://capitalatlas.ai/funds/scottish-widows-investment-partnership) — Series C
- Alice Ventures (https://capitalatlas.ai/funds/alice-ventures) — Series C
- Phase4 Partners (https://capitalatlas.ai/funds/phase4-partners) — Series C
- Novo Holdings — Series C
- Finsbury Life Sciences Investment Trust — Series C
